(Q33611412)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28503156%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

review article

1 reference

title

Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal 1H-MRS Studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28503156%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28503156%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Agata Szulc

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28503156%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Philip McGuire

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28503156%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Alice Egerton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28503156%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Akarmi Bhachu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28503156%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Grant McQueen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28503156%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

28 April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28503156%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

published in

Frontiers in Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28503156%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28503156%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28503156%20AND%20SRC:MED&resulttype=core&format=json

Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies

20 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Proton magnetic resonance spectroscopy measures related to short-term symptomatic outcome in chronic schizophrenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Long term antipsychotic treatment does not alter metabolite concentrations in rat striatum: an in vivo magnetic resonance spectroscopy study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Glutamatergic theories of schizophrenia.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

1H-MRS at 4 tesla in minimally treated early schizophrenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Antipsychotic drug actions on gene modulation and signaling mechanisms

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Neurocircuitries and neurotransmitter interactions in schizophrenia.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume.

21 June 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2017.00066

Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2017.00066

Analyzing the effects of psychotropic drugs on metabolite profiles in rat brain using 1H NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2017.00066

Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2017.00066

Different effects of a single and repeated administration of clozapine on phencyclidine-induced hyperlocomotion and glutamate releases in the rat medial prefrontal cortex at short- and long-term withdrawal from this antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2017.00066

Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2017.00066

Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2017.00066

Long-term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2017.00066

Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2017.00066

Effects of quetiapine on monoamine, GABA, and glutamate release in rat prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2017.00066

Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2017.00066

Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2017.00066

Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2017.00066

Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2017.00066

Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2017.00066

The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2017.00066

The 5-HT receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2017.00066

The effect of chronic haloperidol treatment on glutamate receptor subunit (GluR1, GluR2, KA1, KA2, NR1) mRNAs and glutamate binding protein mRNA in rat forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2017.00066

[Glutamate increase in the associative striatum in schizophrenia: a longitudinal magnetic resonance spectroscopy preliminary study].

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5408014

Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28503156

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Grey matter and social functioning correlates of glutamatergic metabolite loss in schizophrenia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28503156

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3389/FPSYT.2017.00066

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28503156%20AND%20SRC:MED&resulttype=core&format=json

release_n2owxsuq2fci3dgkaqfsniznoi

20 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/n2owxsuq2fci3dgkaqfsniznoi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28503156%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

PubMed publication ID

28503156

1 reference